Colonoscopic evaluation in ulcerative colitis

Colonoscopic evaluation is an important tool in the evaluation of ulcerative colitis (UC). UC is divided by disease extent into proctitis, proctosigmoiditis, left-sided colitis, and pan-colitis. In addition, a cecal or peri-appendiceal patch and backwash ileitis are associated with UC. The extent and behavior of UC has been characterized further using various indices and scoring systems; among these systems is the Mayo Score, which is widely used in current clinical trials for new medications. As these medical therapies for UC have developed, achieving mucosal healing with medications has become an important therapeutic objective.

[1]  S. Truelove,et al.  Biopsy Studies in Ulcerative Colitis , 1956, British medical journal.

[2]  C. Meijer,et al.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. , 1991, Gut.

[3]  B. Korelitz.  Mucosal healing as an index of colitis activity: back to histological healing for future indices. , 2010, Inflammatory bowel diseases.

[4]  J. Mendoza,et al.  Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. , 2011, European journal of internal medicine.

[5]  R. W. Hughes.  Endoscopic Interpretation: Normal and Pathologic Appearances of the Gastrointestinal Tract , 1985 .

[6]  Masahiro Ito,et al.  Proximal extension of backwash ileitis in ulcerative-colitis - associated colon cancer. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[7]  D. Rubin,et al.  Randomised clinical trial: delayed‐release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing – ASCEND I and II combined analysis , 2011, Alimentary pharmacology & therapeutics.

[8]  R. D'Incà,et al.  Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study , 2012, Inflammatory bowel diseases.

[9]  C. Smith,et al.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. , 1986, Gut.

[10]  G. Rogler,et al.  Mucosal healing and deep remission: what does it mean? , 2013, World journal of gastroenterology.

[11]  E. Langholz.  Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. , 1999, Danish medical bulletin.

[12]  D. Rubin,et al.  The Peri-appendiceal Red Patch in Ulcerative Colitis: Review of the University of Chicago Experience , 2010, Digestive Diseases and Sciences.

[13]  D. Altman,et al.  Reliability and initial validation of the ulcerative colitis endoscopic index of severity. , 2013, Gastroenterology.

[14]  S. Vermeire,et al.  Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management , 2012 .

[15]  J. H. Baron,et al.  Variation Between Observers in Describing Mucosal Appearances in Proctocolitis* , 1964, British medical journal.

[16]  Matts Sg,et al.  THE VALUE OF RECTAL BIOPSY IN THE DIAGNOSIS OF ULCERATIVE COLITIS1 , 1961 .

[17]  G. D'Haens,et al.  Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. , 2012, Gastroenterology.

[18]  P. Gionchetti,et al.  Problematic proctitis and distal colitis , 2004 .

[19]  B. Feagan,et al.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. , 2016, The Cochrane database of systematic reviews.

[20]  H. Steinhart,et al.  Clinical guidelines for the medical management of left‐sided ulcerative colitis and ulcerative proctitis: Summary statement , 2006, Inflammatory bowel diseases.

[21]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[22]  S. Schreiber,et al.  Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial , 2011, Gut.

[23]  A. Zinsmeister,et al.  Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity , 2011, Inflammatory bowel diseases.

[24]  A. Forbes,et al.  Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk , 2004, Gut.

[25]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[26]  P. Rutgeerts,et al.  Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. , 2014, Gastroenterology.

[27]  J. Cotter,et al.  Review of the disease course among adult ulcerative colitis population‐based longitudinal cohorts , 2012, Inflammatory bowel diseases.

[28]  M. Neurath,et al.  Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.

[29]  D. Altman,et al.  Translational Gastroenterology , 2011 .

[30]  F. Autschbach,et al.  Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. , 2001, Gastroenterology.

[31]  G. Porro,et al.  Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  K. Kelly,et al.  Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis , 1987, Diseases of the colon and rectum.

[33]  A. Zinsmeister,et al.  Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .

[35]  M. Shimizu,et al.  Significance of appendiceal involvement in patients with ulcerative colitis. , 2002, Gastrointestinal endoscopy.

[36]  S G MATTS,et al.  The value of rectal biopsy in the diagnosis of ulcerative colitis. , 1961, The Quarterly journal of medicine.

[37]  R. Wright,et al.  Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets , 1966, The American Journal of Digestive Diseases.

[38]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[39]  P. Rutgeerts,et al.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.

[40]  P. Rutgeerts,et al.  Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. , 2014, Gastroenterology.

[41]  Robert C Langan,et al.  Ulcerative colitis: diagnosis and treatment. , 2007, American family physician.

[42]  E. Cabré,et al.  Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. , 2011, Journal of gastrointestinal and liver diseases : JGLD.

[43]  O. Paoluzi,et al.  Azathioprine or methotrexate in the treatment of patients with steroid‐dependent or steroid‐resistant ulcerative colitis: results of an open‐label study on efficacy and tolerability in inducing and maintaining remission , 2002, Alimentary pharmacology & therapeutics.

[44]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[45]  P. Gionchetti,et al.  Review article: problematic proctitis and distal colitis. , 2004, Alimentary pharmacology & therapeutics.

[46]  Philippe Marteau,et al.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.

[47]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[48]  D. Faigel,et al.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. , 2006, Gastrointestinal endoscopy.

[49]  F. Remzi,et al.  Backwash Ileitis and the Risk of Colon Neoplasia in Ulcerative Colitis Patients Undergoing Restorative Proctocolectomy , 2013, Digestive Diseases and Sciences.

[50]  M. Regueiro.  Diagnosis and treatment of ulcerative proctitis. , 2004, Journal of clinical gastroenterology.

[51]  A. Cohen,et al.  Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. , 2005, The New England journal of medicine.

[52]  Hui-Fei Cui,et al.  Different therapy for different types of ulcerative colitis in China. , 2004, World journal of gastroenterology.

[53]  Paul Rutgeerts,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.

[54]  S. Truelove.  Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. , 1954, Gastroenterologia.

[55]  S. Stryker,et al.  Appendiceal involvement as a skip lesion in ulcerative colitis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[56]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[57]  S. Riley,et al.  Microscopic activity in ulcerative colitis: what does it mean? , 1991, Gut.

[58]  M. Vatn,et al.  Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.

[59]  L. Sutherland,et al.  5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. , 1987, Gastroenterology.

[60]  O. Fratila,et al.  Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[61]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[62]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[63]  A. Thuraisingam,et al.  Medical management of ulcerative colitis. , 2003, Hospital medicine.

[64]  P. Rutgeerts,et al.  Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. , 1997, The American journal of gastroenterology.

[65]  A. Saniabadi,et al.  Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.